PNEUMOPATH - A comprehensive dissection of pneumococcal-host interactions
- EC contribution
- : € 2.999.843
- Duration
- : 36 months
- Starting date
- : 1/01/2009
- Funding scheme
- : Focused research project
- Keywords
- : Pneumococcus, virulence, genomics, antibiotic resistance, epidemiology, systems biology, models of infection, genetics
- Contract/Grant agreement number
- : 222983
- Project web-site
- : http://www.pneumopath.org/
Summary:
This project is a fundamental, comprehensive study of the host-pathogen interactions during infection with Streptococcus pneumoniae. The expectation is that the basic knowledge gained from this work will give new targets for vaccination, diagnosis and treatment. In PNEUMOPATH, academic and industrial partners will work together in six scientific workpackages.
- The molecular epidemiology of antibiotic resistant pneumococci
- The genetic basis of disease susceptibility in the human host and in mice
- Molecular aspects of virulence and host response in animal models of pneumococcal carriage and disease
- Molecular aspects of virulence and host response in human cell culture systems
- Pneumococcal cell biology to determine the role of central metabolic processes and the link to virulence
- Integrated bioinformatics and data management
It is accepted that the outcome of pneumococcal infection is determined by the interplay of both host and pathogen attributes. Pneumococcal isolates vary in the repertoire of genes that they possess. Hence the contribution of an individual factor to the infectious process may vary according to the other host and pathogen factors that are present. To date, study of infection has tended to be a reductionist approach, considering the contribution of each virulence factor or host factor in isolation. Consequently, in searching for targets for antimicrobial therapy or for enhancement of host defence, the contribution of individual factors may be inaccurately estimated. This project will be radically different. Rather than using targeted mutagenesis to create strains of different phenotype for testing, PNEUMOPATH will be a systems biology approach with a checkerboard experimental design. Panels of resistant / non-resistant carriage and disease pneumococcal isolates will be used to challenge in in vivo and in vitro models, followed by integrated management and analysis of the data with a new semantic web bioinformatic infrastructure.
Problem:
Transmission of Streptococcus pneumoniae to a new host can result in clearance, asymptomatic colonisation or progress to invasive disease. To date, study of infection has tended to be a reductionist approach, considering the contribution of each virulence factor or host factor in isolation. Consequently, in searching for targets for antimicrobial therapy or for enhancement of host defence, the contribution of individual factors may be inaccurately estimated.
Aim:
Through a systems approach to host-pneumococcal interaction, identify the most important and consistently involved host and pneumococcal factors.
Results:
Identification of new targets for vaccination, diagnosis and treatment of pneumococcal disease.
Potential applications:
Targets for diagnosis, therapy, enhancement of host defence and prophylaxis.
Coordinator:
University of Leicester
Maurice Shock Building
University Road
Leicester
LE1 9HN
UK
E-mail: pwa@leicester.ac.uk
Partners:
CNRS-Université Paul Sabatier,
Laboratoire de Microbiologie et Génétique Moléculaires
UMR5100
118, route de Narbonne,
31062 Toulouse cedex 09
France
E-mail: claverys@ibcg.biotoul.fr
Professor Peter Hermans
Radboud University Nijmegen Medical Centre,
Laboratory of Pediatric Infectious Diseases
PO Box 9101
6500 HB Nijmegen
The Netherlands
E-mail: p.hermans@cukz.umcn.nl
Professor Birgitta Henriques-Normark
Swedish Institute for Infectious Disease Control,
Dept. of Bacteriology
S-171 82 Solna
Sweden
E-mail: birgitta.henriques@smi.ki.se
Dr. Ingileif Jonsdottir
deCODE genetics,
Division of Infectious and Inflammatory Diseases
Sturlugata 8
IS - 101 Reykjavik
Iceland
E-mail: ingileif.jonsdottir@decode.is
Professor Marco Oggioni
University of Siena
LA.M.M.B, Dipartimento di Biologia Molecolare
Policlinico Le Scotte (lotto 5; piano 1)
53100 Siena
Italy
E-mail: oggioni@unisi.it
Professor Regine Hakenbeck
University of Kaiserslautern,
Department of Microbiology
Paul Ehrlich Str., 23,
D-67663 Kaiserslautern
Germany
E-mail: hakenb@rhrk.uni-kl.de
Professor Herminia de Lencastre
Instituto de Tecnologia Quimica e Biologica,
Laboratory of Molecular Genetics
Rua da Quinta Grande, 6 - Apt.127
2780-156 Oeiras
Portugal
E-mail: hml@itqb.unl.pt
Professor Oscar Kuipers
University of Groningen,
Groningen Biomolecular Sciences and Biotechnology Institute,
Kerklaan 30,
9751 NN Haren
The Netherlands
E-mail: o.p.kuipers@rug.nl
Dr. Nicholas Lindley
Institut National des Sciences Appliquees,
Laboratoire d'Ingénierie des Systèmes Biologiques et des Procédés
135 Avenue de Rangueil,
31077 Toulouse cedex 4
E-mail: lindley@insa-toulouse.fr
Professor Jonas Almeida
Instituto de Engenharia de Sistemas e Computadores,
Rua Alves Redol 9, Apartado 13069
1000-029 Lisboa
Portugal
E-mail: jalmeida@mathbiol.org
Dr. Andreas Meinke
Intercell AG,
Pre-clinical Research and Development
Intercell AG
Vienna Biocenter 6
A-1030 Vienna,
Austria
E-mail: AMEINKE@intercell.com
Dr. Paul Denny
MRC Mammalian Genetics Unit,
Infection Genetics
Harwell, OX11 0RD, UK
E-mail: p.denny@har.mrc.ac.uk
Professor Staffan Normark
Karolinska Institutet,
Department of Microbiology,
Tumor and Cell Biology
Nobelsväg 16
SE-17177 Stockholm
Sweden
E-mail: staffan.normark@smi.ki.se
Dr. Kees Leenhouts
Mucosis BV,
Meditech Center
Room Z224
L.J. Zielstraweg 1
9713 GX Groningen,
The Netherlands
E-mail: p.hermans@cukz.umcn.nl
Dr. Herman Groen
IQ Therapeutics BV,
Rozenburglaan 13A
NL-9747 DL Groningen
The Netherlands
E-mail: h.groen@iqtherapeutics.nl


